Response Assessment in Metastatic Melanoma Treated With Ipilimumab and Bevacizumab: CT Tumor Size and Density as Markers for Response and Outcome

Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/s40425-014-0040-2

Related search